×

We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now

US pharmaceutical manufacturer Johnson & Johnson (J&J) has launched a new satellite research site at the University of Cape Town’s (UCT’s) Holistic Drug Discovery and Development (H3D) Centre, that aims to devise new treatments for drug-resistant pathogens.

Drug resistance arises when bacteria, fungi or viruses mutate and develop the ability to evade the treatments designed to kill them...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now